BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33704529)

  • 1. Acute kidney injury adversely affects the clinical course of acute myeloid leukemia patients undergoing induction chemotherapy.
    Ballo O; Eladly F; Büttner S; Stratmann JA; Rudolf S; Brunnberg U; Kreisel EM; Steffen B; Wagner S; Finkelmeier F; Serve H; Brandts CH
    Ann Hematol; 2021 May; 100(5):1159-1167. PubMed ID: 33704529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.
    Lahoti A; Kantarjian H; Salahudeen AK; Ravandi F; Cortes JE; Faderl S; O'Brien S; Wierda W; Mattiuzzi GN
    Cancer; 2010 Sep; 116(17):4063-8. PubMed ID: 20564156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colonization with multidrug resistant organisms determines the clinical course of patients with acute myeloid leukemia undergoing intensive induction chemotherapy.
    Ballo O; Tarazzit I; Stratmann J; Reinheimer C; Hogardt M; Wichelhaus TA; Kempf V; Serve H; Finkelmeier F; Brandts C
    PLoS One; 2019; 14(1):e0210991. PubMed ID: 30673776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia.
    Tober R; Schnetzke U; Fleischmann M; Yomade O; Schrenk K; Hammersen J; Glaser A; Thiede C; Hochhaus A; Scholl S
    J Cancer Res Clin Oncol; 2023 Apr; 149(4):1569-1583. PubMed ID: 35583829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluid overload is associated with increased 90-day mortality in AML patients undergoing induction chemotherapy.
    Ballo O; Eladly F; Koschade S; Büttner S; Stratmann JA; Brunnberg U; Kreisel EM; Frank F; Wagner S; Steffen B; Serve H; Finkelmeier F; Brandts CH
    Ann Hematol; 2021 Oct; 100(10):2603-2611. PubMed ID: 34304288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of acute kidney injury during chemotherapy for childhood acute myeloid leukemia.
    Du Plessis L; Rassekh SR; Mammen C
    Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy.
    Park H; Youk J; Shin DY; Hong J; Kim I; Kim NJ; Lee JO; Bang SM; Yoon SS; Park WB; Koh Y
    BMC Cancer; 2019 Apr; 19(1):358. PubMed ID: 30991992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.
    Vaughn JE; Othus M; Powell MA; Gardner KM; Rizzuto DL; Hendrie PC; Becker PS; Pottinger PS; Estey EH; Walter RB
    JAMA Oncol; 2015 Nov; 1(8):1120-7. PubMed ID: 26355382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical features and early treatment effects in intermediate risk and poor risk acute myeloid leukemia with EVI1 positive].
    Duan WB; Gong LZ; Jia JS; Zhu HH; Zhao XS; Jiang Q; Zhao T; Wang J; Qin YZ; Huang XJ; Jiang H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 49(6):990-995. PubMed ID: 29263470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapy.
    Ballo O; Kreisel EM; Eladly F; Brunnberg U; Stratmann J; Hunyady P; Hogardt M; Wichelhaus TA; Kempf VAJ; Steffen B; Vehreschild JJ; Vehreschild MJGT; Finkelmeier F; Serve H; Brandts CH
    Ann Hematol; 2020 Nov; 99(11):2547-2553. PubMed ID: 32974837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Tumor Infiltration and Severe Acute Kidney Injury in Patients with Acute Myeloblastic Leukemia.
    Aratani S; Aburakawa S; Ryotokuji T; Marumo A; Sakai Y; Inokuchi K; Tsuruoka S
    J Nippon Med Sch; 2020 Mar; 87(1):43-48. PubMed ID: 31902852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracranial hemorrhage in newly diagnosed non-promyelocytic acute myeloid leukemia patients admitted for intensive induction chemotherapy.
    Koschade SE; Stratmann JA; Miesbach W; Steffen B; Serve H; Finkelmeier F; Brandts CH; Ballo O
    Eur J Haematol; 2022 Feb; 108(2):125-132. PubMed ID: 34714547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study.
    Lien MY; Chou CH; Lin CC; Bai LY; Chiu CF; Yeh SP; Ho MW
    PLoS One; 2018; 13(6):e0197851. PubMed ID: 29883443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute kidney injury and childhood acute myeloid leukemia.
    Limratchapong C; Sophark P; Vachvanichsanong P; McNeil EB; Chotsampancharoen T
    Pediatr Nephrol; 2022 Nov; 37(11):2765-2770. PubMed ID: 35257241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive fungal infection following chemotherapy for acute myeloid leukaemia-Experience from a developing country.
    Korula A; Abraham A; Abubacker FN; Viswabandya A; Lakshmi KM; Abraham OC; Rupali P; Varghese GM; Michael JS; Srivastava A; Mathews V; George B
    Mycoses; 2017 Oct; 60(10):686-691. PubMed ID: 28736936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Time Between Induction Chemotherapy and Complete Remission on Survival Outcomes in Patients With Acute Myeloid Leukemia.
    Ciftciler R; Demiroglu H; Haznedaroglu IC; Sayınalp N; Aksu S; Ozcebe O; Goker H; Aydın MS; Buyukasık Y
    Clin Lymphoma Myeloma Leuk; 2019 Nov; 19(11):729-734. PubMed ID: 31540855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fate of patients with acute myeloid leukemia not undergoing induction chemotherapy.
    Yanada M; Okamoto A; Inaguma Y; Tokuda M; Morishima S; Kanie T; Yamamoto Y; Mizuta S; Akatsuka Y; Okamoto M; Emi N
    Int J Hematol; 2015 Jul; 102(1):35-40. PubMed ID: 25822047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study).
    Candoni A; Farina F; Perruccio K; Di Blasi R; Criscuolo M; Cattaneo C; Delia M; Zannier ME; Dragonetti G; Fanci R; Martino B; Del Principe MI; Fianchi L; Vianelli N; Chierichini A; Garzia M; Petruzzellis G; Nadali G; Verga L; Busca A; Pagano L
    Mycoses; 2020 Oct; 63(10):1094-1100. PubMed ID: 32697010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute kidney injury in children with haematological malignancy: a territory-wide study.
    Lam SY; Chan EY; Cheng FWT; Ma ALT; Ha SY
    Pediatr Nephrol; 2023 Nov; 38(11):3823-3833. PubMed ID: 37219640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of efficacy and prognosis of induction chemotherapy in 76 elderly patients with acute myeloid leukemia (non-APL)].
    Yang H; Niu JH; Zhu CY; Zhang Q; Zhu HY; Yao ZL; Zhou MH; Wang QS; Yu L; Jing Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):957-64. PubMed ID: 25130810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.